2-{[3-(Pyridin-4-yl)propoxy]carbonyl}benzoic acid, 1g

9-Chloro-5,6,7,8-tetrahydroacridine-3-carboxylic acid, 95.0%, 1g

Sesamin, >98.0%(GC), 250mg

2-Methyl-1,4-benzoquinone, 97.0%, 500g

(S)-2-((((9H-Fluoren-9-yl)methoxy)carbonyl)amino)-3-(4-(2-((tert-butoxycarbonyl)amino)ethoxy)phenyl)propanoic acid, 97%, 100g

N-Cyano-4-methyl-N-phenylbenzenesulfonamide, 95.0%, 100g

6-Bromo-2-fluoro-3-methylbenzonitrile, 97%, 5g

3,3'-Dichloro-4,4'-diisocyanatobiphenyl>95.0%(T)5g

6-Ethoxy-2-methylpyridine-3-boronic acid, 98%, 250mg

2-(3-(CYCLOPENTYLOXY)-4-METHOXYPHENYL)ACETONITRILE, 95.0%, 5g

(R)-3-CYCLOHEXYLMORPHOLINE, 95%, 1g

1-(Cyclopropylsulfonyl)-1,4-diazepane, 95%, 100mg

Ligasi T4, 500 µl, 5x 500 U